1. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
   Ayako Nakamura et al, 2014, Gastric Cancer CrossRef
2. The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
   Chang Su et al, 2023, Cancers CrossRef
3. Folic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2′-Deoxyuridine in Colorectal Cancer Cell Lines
   Hiroshi Tsukihara et al, 2016, PLOS ONE CrossRef
4. A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer
   M.A. West et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
5. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery
   Wei Liu et al, 2018, Molecules CrossRef
6. Levoleucovorin as Replacement for Leucovorin in Cancer Treatment
   Victor Tuan Giam Chuang et al, 2012, Annals of Pharmacotherapy CrossRef
7. Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
   LING CHEN et al, 2015, Oncology Reports CrossRef
8. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway
   Bo Jiang et al, 2016, Tumor Biology CrossRef
9. FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures
   Taylor J. Allen-Coyle et al, 2022, The AAPS Journal CrossRef
10. Ph-Sensitive Nanoparticles Containing 5-Fluorouracil and Leucovorin as An Improved Anti-Cancer Option for Colon Cancer
    Bakry Ibrahim et al, 2022, Nanomedicine CrossRef
11. Maintenance Therapy in Colorectal Cancer: Moving the Artillery Down While Keeping an Eye on the Enemy
    Giuseppe Aprile et al, 2016, Clinical Colorectal Cancer CrossRef